Pileri S - Search Results

1

Retreatment with 2-CdA of progressed HCL patients.

Lauria F, Benfenati D, Raspadori D, Rondelli D, Ventura MA, Pileri S, Sabattini E, Poggi S, Benni M, Tura S. Lauria F, et al. Among authors: pileri s. Leuk Lymphoma. 1994;14 Suppl 1:143-5. Leuk Lymphoma. 1994. PMID: 7820047 Clinical Trial.

2

Bone-marrow biopsy in hairy cell leukaemia (HCL) patients. Histological and immunohistological analysis of 46 cases treated with different therapies.

Pileri S, Sabattini E, Poggi S, Merla E, Raspadori D, Benfenati D, Rondelli D, Benni M, Ventura MA, Falini B, et al. Pileri S, et al. Leuk Lymphoma. 1994;14 Suppl 1:67-71. Leuk Lymphoma. 1994. PMID: 7820056

3

Serum soluble interleukin-2 receptor levels in hairy cell leukemia: correlation with clinical and hematological parameters and with alpha-interferon treatment.

Lauria F, Rondelli D, Raspadori D, Zinzani PL, Benfenati D, Pileri S, Sabattini E, Tura S. Lauria F, et al. Among authors: pileri s. Leuk Lymphoma. 1992 May;7(1-2):103-7. doi: 10.3109/10428199209053608. Leuk Lymphoma. 1992. PMID: 1472920

4

Is Hodgkin's disease a unique entity?

Pileri SA, Poggi S, Sabattini E, De Vivo A, Falini B, Stein H. Pileri SA, et al. Leuk Lymphoma. 1995;15 Suppl 1:3-6. doi: 10.3109/10428199509052694. Leuk Lymphoma. 1995. PMID: 7767257 Review.

5

Anaplastic large cell lymphoma: update of findings.

Pileri SA, Piccaluga A, Poggi S, Sabattini E, Piccaluga PP, De Vivo A, Falini B, Stein H. Pileri SA, et al. Leuk Lymphoma. 1995 Jun;18(1-2):17-25. doi: 10.3109/10428199509064918. Leuk Lymphoma. 1995. PMID: 8580821 Review.

6

Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B-cell proliferation.

Monteverde A, Sabattini E, Poggi S, Ballarè M, Bertoncelli MC, De Vivo A, Briskomatis A, Roncador G, Falini B, Pileri SA. Monteverde A, et al. Among authors: pileri sa. Leuk Lymphoma. 1995 Dec;20(1-2):119-24. doi: 10.3109/10428199509054762. Leuk Lymphoma. 1995. PMID: 8750632

7

Interferon-alpha effects on stromal compartment of normal and chronic myeloid leukemia hematopoiesis.

Santucci MA, Soligo D, Pileri S, Zuffa E, Testoni N, Tura S. Santucci MA, et al. Among authors: pileri s. Leuk Lymphoma. 1993;11 Suppl 1:113-8. doi: 10.3109/10428199309047873. Leuk Lymphoma. 1993. PMID: 8251886 No abstract available.

8

Long-term follow-up of hairy cell leukemia patients treated with 2-chlorodeoxyadenosine.

Zinzani PL, Magagnoli M, Bendandi M, Tani M, Stefoni V, Cellini C, Poggi S, Piccioli M, Pileri S, Tura S. Zinzani PL, et al. Among authors: pileri s. Haematologica. 2000 Sep;85(9):922-5. Haematologica. 2000. PMID: 10980629

9

MACOP-B vs F-MACHOP in the treatment of high-grade non-Hodgkin's lymphomas.

Tura S, Mandelli F, Mazza P, Pileri S, Gherlinzoni F, Bocchia M, Zinzani PL, Fiacchini M, Martelli M, Papa G, et al. Tura S, et al. Among authors: pileri s. Leukemia. 1991;5 Suppl 1:74-8. Leukemia. 1991. PMID: 1716338 Clinical Trial.

10

Evaluation of complete remission in hairy cell leukemia patients treated with alpha-IFN.

Lauria F, Foà R, Raspadori D, Pileri S, Tassinari A, Buzzi M, Zaccaria A, Zinzani PL, Tura S. Lauria F, et al. Among authors: pileri s. Bone Marrow Transplant. 1989 Jan;4 Suppl 1:176-8. Bone Marrow Transplant. 1989. PMID: 2785426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

737 results

Search Page

Filters